Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Pardes Biosciences
Pardes Biosciences
Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial
Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial
Endpoints
Pardes Biosciences
antivirals
COVID-19
Flag link:
Pardes initiates Phase II trial of Covid-19 antiviral drug
Pardes initiates Phase II trial of Covid-19 antiviral drug
Clinical Trials Arena
Pardes Biosciences
PBI-0451
COVID-19
antivirals
Flag link:
Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal
Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal
BioPharma Dive
antivirals
COVID-19
Gilead Sciences
Foresite
Pardes Biosciences
Flag link:
